Doctor profile · Federal record
Dr. Jane Schneider, M.D.
Dermatology Physician (CMS: Dermatology) · New York, NY
- NPI 1518163849
- Accepts Medicare
- MIPS 80.5 / 100 · 2023
- 21 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
250 W 57Th St, Suite 825
New York, NY 101070001
(212) 489-6669 - Mailing address
-
421 Degraw St, #1A
Brooklyn, NY 112172946
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- April 17, 2014
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #242960
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518163849. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,061
Distinct HCPCS
9
Medicare allowed
$89,202
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 405 | 281 | $103 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 192 | 62 | $8 | |
17000 |
Destruction of precancer skin growth, 1 growth | 138 | 111 | $66 | |
11102 |
Biopsy of related skin growth, first growth | 112 | 94 | $115 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 61 | 53 | $145 | |
17110 |
Destruction of skin growth, 1-14 growths | 55 | 44 | $133 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 35 | 31 | $65 | |
11103 |
Biopsy of related skin growth, each additional growth | 33 | 20 | $59 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 30 | 30 | $129 |
In context: peer comparison
Among 139 peers in this city , average services per provider: 182. This provider delivers 5.8× the peer median.Open Payments
Industry payments received
All-time total
$2,171
Transactions
142
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 24 | $328.96 | |
| Lilly USA, LLC | 13 | $227.25 | |
| Almirall LLC | 16 | $206.88 | |
| Dermavant Sciences, Inc. | 13 | $178.98 | |
| Janssen Biotech, Inc. | 14 | $170.88 | |
| LEO Pharma Inc. | 15 | $151.02 | |
| Incyte Corporation | 11 | $145.33 | |
| Regeneron Healthcare Solutions, Inc. | 9 | $138.88 | |
| Amgen Inc. | 6 | $133.80 | |
| GENZYME CORPORATION | 4 | $122.88 | |
| Novartis Pharmaceuticals Corporation | 5 | $115.57 | |
| PFIZER INC. | 5 | $91.59 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $81.39 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $29.63 | |
| Tactile Systems Technology Inc | 1 | $20.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
274
Patients
123
Total drug cost
$7,282
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 54 | 40 | $613 |
| Ketoconazole | Generic | 52 | 37 | $1,091 |
| Clindamycin Phosphate | Generic | 28 | 0 | $622 |
| Clobetasol Propionate | Generic | 21 | 18 | $1,135 |
| Mupirocin | Generic | 21 | 14 | $116 |
| Nystatin | Generic | 20 | 0 | $258 |
| Hydrocortisone | Generic | 19 | 14 | $105 |
| Tretinoin | Generic | 19 | 0 | $1,108 |
| Finasteride | Generic | 15 | 0 | $266 |
| Doxycycline Hyclate | Generic | 14 | 0 | $264 |
Frequently asked questions
What is Dr. Jane Schneider's medical specialty?
Dr. Jane Schneider practices Dermatology Physician in New York, NY.
Where does Dr. Jane Schneider practice?
Dr. Jane Schneider practices at 250 W 57Th St, New York, NY 101070001. Office phone: 2124896669.
What is Dr. Jane Schneider's NPI?
Dr. Jane Schneider's National Provider Identifier (NPI) is 1518163849, issued by NPPES.
Does Dr. Jane Schneider accept Medicare assignment?
Yes. Dr. Jane Schneider accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jane Schneider commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.